PDS Biotechnology Corp. Stock
€3.55
Your prediction
PDS Biotechnology Corp. Stock
Pros and Cons of PDS Biotechnology Corp. in the next few years
Pros
Cons
Performance of PDS Biotechnology Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| PDS Biotechnology Corp. | 2.830% | 16.078% | 3.076% | -35.769% | -22.866% | - | - |
| Vaxart Inc. | -5.240% | 9.535% | -41.053% | -15.301% | 30.334% | -89.873% | - |
| Larimar Therapeutics Inc. | 8.660% | - | - | - | - | - | - |
| Jaguar Health Inc. | 9.340% | 75.895% | 329.738% | 276.982% | 95.232% | -99.892% | - |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.PDS Biotech, a prominent player in the biotechnology and medical research industry, appears to be in a somewhat strong financial position based on the data provided. The company has a sizable amount of cash on hand and has been consistently increasing its total assets over the years. However, the data also reveals certain areas of concern, such as growing net losses and a lack of revenue generation. In this article, we will delve deep into the financials of the company and discuss both the positives and negatives.
Growing Total Assets: PDS Biotech has displayed a consistent growth in its total assets over the years, increasing from $30,890,379 in 2020 to $77,007,923 in 2022. This trend signifies the company's ability to accumulate assets, which can potentially be used to finance future growth.
Solid Cash Position: The company has maintained a strong cash position throughout the years. Cash reserves increased from $28,839,565 in 2020 to $73,820,160 in 2022. This large cash balance provides the company with financial flexibility and can be used to support ongoing research and development efforts as well as fuel potential acquisitions and partnerships.